100mg Rituximab Injection IP

Get a Price/Quote

MOQ : 100 Packs

100mg Rituximab Injection IP Specification

Indication
Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis

Packaging Type
Vial

Pacakaging (Quantity Per Box)
1 vial per box

Brand Name
Rituximab Injection IP

Origin of Medicine
India

Life Span
24 months from manufacture date

Dosage Form
Injection

Salt Composition
Rituximab 100mg

Drug Type
Biological/Monoclonal Antibody

Ingredients
Rituximab

Physical Form
Liquid

Function
Anti-cancer, immunosuppressant (monoclonal antibody) therapy

Recommended For
Adults with Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis; as per physicians advice

Dosage
As directed by the physician; typically administered as an IV infusion

Dosage Guidelines
Administer under medical supervision, dosage as per physicians instructions

Suitable For
Adults

Quantity
1 Vial

Storage Instructions
Store at 2C to 8C. Do not freeze. Protect from light.

Prescription Required
Yes

Special Precautions
Monitor for infusion reactions, infections, and cardiac events during administration

Therapeutic Class
Anti-neoplastic agents

Compatibility
Compatible with standard IV infusion equipment

Marketed By
As per packaging (not specified)

Strength
100 mg per 10 mL vial

Reconstitution Required
No, ready to use

MRP
As per packaging (not specified)

Route of Administration
Intravenous (IV) infusion

Appearance
Clear to slightly opalescent, colorless to pale yellow solution

100mg Rituximab Injection IP Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
10 Days

Main Domestic Market
All India

100mg Rituximab Injection IP About

Spotlight your therapy with Rituximab Injection IP 100mg, a peerless monoclonal antibody renowned for its premier role in treating Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, and Rheumatoid Arthritis. This clear to slightly opalescent solution is ready-to-use, requiring no reconstitution, ensuring swift and seamless administration. Commanding favorable reviews from medical professionals, Rituximab is compatible with standard IV equipment and must be given under expert supervision. Explore effective cancer and immunosuppressant support with this top-tier anti-neoplastic agent. Prescription required. Store between 2C and 8C; safeguard from light.

Distinctive Features & Competitive Advantages

Rituximab Injection IP 100mg shines with its ready-to-use vial, eliminating the need for reconstitution and minimizing setup time. It boasts high stability and compatibility with standard IV infusion equipment, ensuring hassle-free usage. With a shelf life of 24 months and precision storage guidelines, it upholds efficacy and safety throughout its use. This injection's distinguished performance, backed by favorable clinician feedback, further asserts its commanding position in advanced monoclonal antibody therapy for adults.

Supply, Logistics & Export Excellence

Our Rituximab Injection IP 100mg is reliably supplied in secure, single-vial boxes for optimum safety during handover and transport. With a robust export network, we efficiently serve premier markets across Asia, Africa, the Middle East, and Latin America. Packaging details and logistics are meticulously managed to preserve product integrity. Our supply ability and streamlined export processes guarantee that the medication consistently arrives in optimal condition, ready for prompt distribution to medical facilities worldwide.

FAQ's of 100mg Rituximab Injection IP:

Q: How should Rituximab Injection IP 100mg be stored and handled?

A: Keep the vial at 2C to 8C, protected from light. Do not freeze. Handle the injection carefully and only administer under medical supervision.

Q: What conditions is Rituximab Injection IP 100mg indicated for?

A: It is indicated for treating Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, and Rheumatoid Arthritis in adults, as directed by a physician.

Q: What is the process for administering Rituximab Injection IP 100mg?

A: This injection is administered via intravenous (IV) infusion using standard IV equipment. Only healthcare professionals should carry out the administration, monitoring for infusion reactions and other side effects.

Q: When should I consult my doctor before using Rituximab Injection IP 100mg?

A: Consult your doctor prior to each infusion, especially if you experience any infections, heart conditions, or infusion reactions. Dosage and timing must always be determined by your physician.

Q: What benefits does Rituximab Injection IP 100mg offer over other therapies?

A: Rituximab provides targeted monoclonal antibody therapy that has been proven effective in managing specific cancers and autoimmune conditions, often with favorable outcomes as reviewed by healthcare professionals.

Tell us about your requirement